NCT01487161View on ClinicalTrials.gov

Study of FX006 in Patients With Osteoarthritis of the Knee

PHASE2CompletedINTERVENTIONAL
Enrollment

229

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

April 30, 2013

Study Completion Date

April 30, 2013

Conditions
Osteoarthritis of the Knee
Interventions
DRUG

FX006

Single 3 mL intra-articular injection

DRUG

TCA IR

Single 1 mL intra-articular injection

Trial Locations (21)

16635

Duncansville

85704

Tucson

Unknown

Broadmeadow

Kogarah

St Leonards

Wollongong

Kippa-Ring

Maroochydore

Sherwood

Clayton

Malvern East

Halifax

Etobicoke

Newmarket

Saint Catherine's

Sarnia

Thornhill

Waterloo

Windsor

Montreal

Sainte-Foy

Sponsors
All Listed Sponsors
lead

Pacira Pharmaceuticals, Inc

INDUSTRY